Pellficure Pharmaceuticals, Inc Report issue

For profit Phase 1
Founded: San Diego CA United States (2011)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2017
NCT03137758
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pellficure Pharmaceuticals, Inc

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 4